KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Total Non-Current Liabilities (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Total Non-Current Liabilities readings, the most recent being $18.3 billion for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 12.93% to $18.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $18.3 billion, a 12.93% decrease, with the full-year FY2025 number at $19.4 billion, down 6.87% from a year prior.
  • Total Non-Current Liabilities hit $18.3 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $19.4 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $25.2 billion in Q1 2022 to a low of $18.3 billion in Q1 2026.
  • Median Total Non-Current Liabilities over the past 5 years was $21.7 billion (2024), compared with a mean of $22.3 billion.
  • Biggest five-year swings in Total Non-Current Liabilities: grew 0.44% in 2023 and later fell 12.93% in 2026.
  • Teva Pharmaceutical Industries' Total Non-Current Liabilities stood at $23.9 billion in 2022, then dropped by 3.5% to $23.1 billion in 2023, then decreased by 9.94% to $20.8 billion in 2024, then fell by 6.87% to $19.4 billion in 2025, then decreased by 5.69% to $18.3 billion in 2026.
  • The last three reported values for Total Non-Current Liabilities were $18.3 billion (Q1 2026), $19.4 billion (Q4 2025), and $21.1 billion (Q3 2025) per Business Quant data.